SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-22-000516
Filing Date
2022-03-25
Accepted
2022-03-25 16:20:47
Documents
51
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K atxi-20211231x10k.htm   iXBRL 10-K 1586931
2 EX-4.3 atxi-20211231xex4d3.htm EX-4.3 21643
3 EX-21.1 atxi-20211231xex21d1.htm EX-21.1 1472
4 EX-23.1 atxi-20211231xex23d1.htm EX-23.1 5298
5 EX-31.1 atxi-20211231xex31d1.htm EX-31.1 13929
6 EX-31.2 atxi-20211231xex31d2.htm EX-31.2 14040
7 EX-32.1 atxi-20211231xex32d1.htm EX-32.1 6728
8 EX-32.2 atxi-20211231xex32d2.htm EX-32.2 6707
  Complete submission text file 0001410578-22-000516.txt   4393114

Data Files

Seq Description Document Type Size
9 EX-101.SCH atxi-20211231.xsd EX-101.SCH 29510
10 EX-101.CAL atxi-20211231_cal.xml EX-101.CAL 23784
11 EX-101.DEF atxi-20211231_def.xml EX-101.DEF 124173
12 EX-101.LAB atxi-20211231_lab.xml EX-101.LAB 227363
13 EX-101.PRE atxi-20211231_pre.xml EX-101.PRE 197886
45 EXTRACTED XBRL INSTANCE DOCUMENT atxi-20211231x10k_htm.xml XML 440029
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38114 | Film No.: 22771691
SIC: 2834 Pharmaceutical Preparations